Trial NCT05791097

View at ClinicalTrials.gov 
Org. Study IDs: CWCD118A12301
Secondary IDs: 2022-503098-12

Last trial update was posted on 2023-07-24

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Paclitaxel Pembrolizumab Pemetrexed Tislelizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer (NSCLC)

Stopping Reasons

Business decision, not driven by safety concerns; no new safety signals have been observed in the ociperlimab program.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID